Bioleaders Corporation Capital Reinvestment Ratio
Bioleaders Corporation capital reinvestment ratio. Bioleaders Corporation (142760) has a Capital Reinvestment Ratio of 21.04x as of September 2024, meaning it reinvests 21% of its operating cash flow (₩49.56 Million) in capital expenditures (₩1.04 Billion). Check Bioleaders Corporation investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bioleaders Corporation (2023–2023)
Capital reinvestment ratio of Bioleaders Corporation from 2023 to 2023. This chart tracks Bioleaders Corporation's Capital Reinvestment Ratio across 1 annual periods. Also explore Bioleaders Corporation (142760) equity growth momentum to track the company's year-over-year net asset growth rate.
Bioleaders Corporation Capital Reinvestment Ratio by Year (2023–2023)
Bioleaders Corporation capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see 142760 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | ₩6.18 Billion | ₩378.81 Million | — |